Isis Reaches New 52-Week High (ISIS)

NEW YORK ( TheStreet) -- Isis Pharmaceuticals (Nasdaq: ISIS) hit a new 52-week high Friday as it is currently trading at $33.63, above its previous 52-week high of $32.86 with 366,992 shares traded as of 10:45 a.m. ET. Average volume has been 1.7 million shares over the past 30 days.

Isis has a market cap of $3.59 billion and is part of the health care sector and drugs industry. Shares are up 203.6% year to date as of the close of trading on Thursday.

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Isis as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow and poor profit margins. You can view the full Isis Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..
null

If you liked this article you might like

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Isis Pharmaceuticals Changes Its Name

Isis Pharmaceuticals Changes Its Name

Highlighted Post-Market Laggard: ISIS Pharmaceuticals (ISIS)

Jim Cramer's 'Mad Money' Recap: Stocks Gain When Analysts Curb Negativity

ISIS Pharmaceuticals (ISIS) Weak On High Volume